Les unités de thérapie cellulaire à l’épreuve de la réglementation sur les médicaments de thérapie innovante
Med Sci (Paris), 30 5 (2014) 576-583
Published online: 2014-06-13
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Participation in SoHO and ATMP public consultations: a fragmented institutional landscape
Michael Morrison, Valentin Brunel and Aurélie MahalatchimyHumanities and Social Sciences Communications 12 (1) (2025)
https://doi.org/10.1057/s41599-025-04552-1
The pharmaceutical circuit of Advanced Therapy Medicinal Products—guidelines of the French Society for Oncology Pharmacy
Bertrand Pourroy, Isabelle Madelaine, Muriel Carvalho, Romain de Jorna, Catherine Devys, Laurence Escalup, Marine Pinturaud, Adeline Quintard, Catherine Rioufol, Sandra Ruitort and Miryam MebarkiCytotherapy (2025)
https://doi.org/10.1016/j.jcyt.2025.04.065
Beyond the Present Constraints That Prevent a Wide Spread of Tissue Engineering and Regenerative Medicine Approaches
Benjamen T. O'Donnell, Clara J. Ives, Omair A. Mohiuddin and Bruce A. BunnellFrontiers in Bioengineering and Biotechnology 7 (2019)
https://doi.org/10.3389/fbioe.2019.00095
Biothérapies, immunothérapies, thérapies ciblées, biomédicaments…
Hervé Watiermédecine/sciences 30 (5) 567 (2014)
https://doi.org/10.1051/medsci/20143005021
Médecine régénératrice du disque intervertébral
Nina Henry, Pauline Colombier, Laurent Lescaudron, et al.médecine/sciences 30 (12) 1091 (2014)
https://doi.org/10.1051/medsci/20143012012